OPPI Medical Excellence Award

OPPI Medical Excellence Award

  • An OPPI Member company
  • Only one entry per member company
  • The initiative/ project conducted between July 2019 - June 2020
  • Cross functional project touching at least 2 or more functions (MA/RA/CO/PV)
  • Demonstrated impact on external stakeholders (e.g. HCPs/Patients)
  • Nomination Categories
    1. New Product Launch
    2. KOL/KTL Engagement
    3. Data Generation/Dissemination
    4. HCP Capability Building
    5. Or any other

    OPPI Medical Excellence Award recognises excellence in Medical Function
    (Medical Affairs / Clinical Operations / Regulatory Affairs / Pharmacovigilance). The jury will assess nominations based on:

  • Ethics: following policies/procedures
  • Innovation: utilising innovative approach
  • Quality: final quality of deliverables
  • Clear outcomes/impact
  • Submission to contain:
    1. Name of project/initiative
    2. Category of nomination e.g. new product launch
    3. Names of medical-regulatory working group member submitting the nomination
    4. Brief description of project:- contribution; innovative solution/ approaches adopted; impact of project
    5. Endorsed by Medical Head and Head of Member Organisation

Dr Arun Bhatt

Consultant - Clinical Research & Development

Dr Milind Antani

Partner, Nishith Desai Associates

Dr Purvish Parikh

Director of Precision Oncology & Research, Asian Institute of Oncology

Dr Rashmi Kulshrestha

Owner (Regulatory Consultant), Regulatory Wisdom

Dr Suresh Menon

Chief Scientific Officer, Rivaara Holdings